Zi-Dong Lu

969 total citations
24 papers, 815 citations indexed

About

Zi-Dong Lu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Zi-Dong Lu has authored 24 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Oncology. Recurrent topics in Zi-Dong Lu's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and RNA Interference and Gene Delivery (5 papers). Zi-Dong Lu is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and RNA Interference and Gene Delivery (5 papers). Zi-Dong Lu collaborates with scholars based in China, United States and Macao. Zi-Dong Lu's co-authors include Cong‐Fei Xu, Jun Wang, Ying‐Li Luo, Yang Liu, Gui Zhao, Song Shen, Zhen Gu, Xianzhu Yang, Zhiting Cao and Anna Czarna and has published in prestigious journals such as Nature Communications, ACS Nano and Biomaterials.

In The Last Decade

Zi-Dong Lu

21 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zi-Dong Lu China	12	523	207	163	109	108	24	815
Su Cheong Yeom South Korea	13	343 0.7×	180 0.9×	50 0.3×	43 0.4×	86 0.8×	33	669
Matin Chehelgerdi Iran	5	398 0.8×	271 1.3×	109 0.7×	220 2.0×	45 0.4×	6	864
Kun Tu China	11	259 0.5×	231 1.1×	167 1.0×	123 1.1×	37 0.3×	12	529
Allison N. DuRoss United States	11	261 0.5×	155 0.7×	53 0.3×	123 1.1×	46 0.4×	15	515
Timo Schomann Netherlands	17	306 0.6×	204 1.0×	154 0.9×	131 1.2×	26 0.2×	35	722
Haonan Xing China	17	686 1.3×	217 1.0×	85 0.5×	117 1.1×	71 0.7×	41	978
Jiayi Pan United States	10	425 0.8×	253 1.2×	58 0.4×	373 3.4×	25 0.2×	14	823
Dan Peer Israel	12	540 1.0×	151 0.7×	93 0.6×	97 0.9×	68 0.6×	24	776
María L. Guevara Peru	12	604 1.2×	198 1.0×	307 1.9×	129 1.2×	125 1.2×	36	1.0k

Countries citing papers authored by Zi-Dong Lu

Since Specialization

Citations

This map shows the geographic impact of Zi-Dong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Dong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Dong Lu more than expected).

Fields of papers citing papers by Zi-Dong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Dong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Dong Lu. The network helps show where Zi-Dong Lu may publish in the future.

Co-authorship network of co-authors of Zi-Dong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Dong Lu. A scholar is included among the top collaborators of Zi-Dong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Dong Lu. Zi-Dong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zi‐Lu, Sheng‐Xiang Qiu, Xiao‐Jiao Du, et al.. (2025). An injectable oncolytic hydrogel platform for in situ dendritic cell vaccination to boost antitumor immunity. Biomaterials Science. 13(11). 3016–3029. 2 indexed citations

Tan, Xinyu, Yifang Chen, Shilun Qiu, et al.. (2025). Tumor-specific suicide gene nanomedicines enable selective and safe cancer treatment. Nano Research. 19(2). 94908294–94908294.

Xie, Xiaochun, Fangman Chen, Jianfang Cao, et al.. (2025). Engineering a Ru(ii) Nanostructure for Oxygen-Free Photocatalytic Degradation of Environmental Pollutants. ACS Applied Materials & Interfaces. 17(12). 18493–18501. 1 indexed citations

Yang, Min, et al.. (2025). Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells. 1(2). 100011–100011. 6 indexed citations

Zeng, Yun‐Yun, Xueqing Zhang, Lili Chen, et al.. (2025). Injectable tert-butylphenylacetic acid/acrylated β-cyclodextrin-based hydrogels for co-delivery of CAR-T cells and IL-15 in solid tumor therapy. Materials Today Bio. 35. 102421–102421.

Chen, Yifang, Zi-Dong Lu, Xueqin Zhang, et al.. (2025). Muscle-specific gene editing therapy via mammalian fusogen-directed virus-like particles. Nature Communications. 16(1). 9145–9145.

Zhang, Yue, Gui Zhao, Jing Liu, et al.. (2023). Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors. Nano Today. 52. 101992–101992. 7 indexed citations

Huang, Xiaoyi, et al.. (2023). Lipid-assisted PEG-b-PLA nanoparticles with ultrahigh SN38 loading capability for efficient cancer therapy. Biomaterials Science. 11(22). 7445–7457. 5 indexed citations

Wang, Yue, Yan Wang, Zi-Dong Lu, et al.. (2023). Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy. Nature Communications. 14(1). 1993–1993. 41 indexed citations

10.

Yang, Liping, et al.. (2023). Tmem88 plays an essential role in pharyngeal pouch progenitor specification by inhibiting Wnt/β-catenin signaling. PubMed. 2(6). lnad044–lnad044. 1 indexed citations

11.

He, Wenjuan, Yue Chen, Jie Cai, et al.. (2023). Personalized Bacteria Loaded with Autoantigens for the Enhancement of Tumor Immunotherapy. Advanced Healthcare Materials. 12(11). e2203026–e2203026. 16 indexed citations

12.

Chen, Yifang, Yan Wang, Ying‐Li Luo, et al.. (2022). Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection. Pharmaceutical Research. 40(1). 145–156. 1 indexed citations

13.

Shi, Jia, Mengwen Huang, Zi-Dong Lu, et al.. (2022). Delivery of mRNA for regulating functions of immune cells. Journal of Controlled Release. 345. 494–511. 42 indexed citations

14.

Wang, Yan, Ying‐Li Luo, Yifang Chen, et al.. (2020). Dually regulating the proliferation and the immune microenvironment of melanomaviananoparticle-delivered siRNA targeting onco-immunologic CD155. Biomaterials Science. 8(23). 6683–6694. 16 indexed citations

15.

Luo, Ying‐Li, Lifang Liang, Jing Liu, et al.. (2020). An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance. ACS Applied Materials & Interfaces. 12(43). 48259–48271. 38 indexed citations

16.

Xu, Cong‐Fei, Guojun Chen, Ying‐Li Luo, et al.. (2019). Rational designs of in vivo CRISPR-Cas delivery systems. Advanced Drug Delivery Reviews. 168. 3–29. 151 indexed citations

17.

Xu, Cong‐Fei, Zi-Dong Lu, Ying‐Li Luo, et al.. (2018). Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases. Nature Communications. 9(1). 4092–4092. 169 indexed citations

18.

Liu, Yang, Zhiting Cao, Cong‐Fei Xu, et al.. (2018). Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation. Biomaterials. 172. 92–104. 60 indexed citations

19.

Cao, Ziyang, Yinchu Ma, Chunyang Sun, et al.. (2017). ROS-Sensitive Polymeric Nanocarriers with Red Light-Activated Size Shrinkage for Remotely Controlled Drug Release. Chemistry of Materials. 30(2). 517–525. 107 indexed citations

20.

Zhang, Qunlin, Yunjing Zhang, Zhongtang Zhang, & Zi-Dong Lu. (2009). Sensitive determination of kaempferol in rat plasma by high-performance liquid chromatography with chemiluminescence detection and application to a pharmacokinetic study. Journal of Chromatography B. 877(29). 3595–3600. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact